ATAPAC Study (TauroLock Activity in Adult Cancer Patients)

NACompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Catheter-Related Infections
Interventions
DEVICE

Taurolock

At the beginning of each course of IV anti-tumor treatment, a nurse removes the lock TauroLock ™ and makes rinsing the CVC. At the end of each course, she rinses again the CVC and instills TauroLock ™ solution. Patients will be followed for each treatment, according to the same rhythm of their anti-tumor treatment program up to the end of the study

DRUG

saline solution

At the beginning of each course of IV anti-tumor treatment, a nurse makes rinsing the CVC. At the end of each course, she rinses again the CVC. Patients will be followed for each treatment, according to the same rhythm of their anti-tumor treatment program up to the end of the study

Trial Locations (1)

57085

Chr Metz Thionville, Metz

All Listed Sponsors
collaborator

centre régional de pharmacovigilance de Nancy

UNKNOWN

collaborator

Theradial

INDUSTRY

lead

Centre Hospitalier Régional Metz-Thionville

OTHER

NCT02279121 - ATAPAC Study (TauroLock Activity in Adult Cancer Patients) | Biotech Hunter | Biotech Hunter